Article info

Download PDFPDF

Association of α1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis
Free

Authors

  • R Mahadeva aRespiratory Medicine Unit, Department of Medicine and Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK, bMRC Biostatistics Unit, Forvie Site, Cambridge, UK, cDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge, UK, dThe Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital, Manchester, UK, eCystic Fibrosis Unit, Papworth Hospital, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  • L Sharples aRespiratory Medicine Unit, Department of Medicine and Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK, bMRC Biostatistics Unit, Forvie Site, Cambridge, UK, cDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge, UK, dThe Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital, Manchester, UK, eCystic Fibrosis Unit, Papworth Hospital, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  • R I Ross-Russell aRespiratory Medicine Unit, Department of Medicine and Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK, bMRC Biostatistics Unit, Forvie Site, Cambridge, UK, cDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge, UK, dThe Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital, Manchester, UK, eCystic Fibrosis Unit, Papworth Hospital, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  • A K Webb aRespiratory Medicine Unit, Department of Medicine and Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK, bMRC Biostatistics Unit, Forvie Site, Cambridge, UK, cDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge, UK, dThe Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital, Manchester, UK, eCystic Fibrosis Unit, Papworth Hospital, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  • D Bilton aRespiratory Medicine Unit, Department of Medicine and Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK, bMRC Biostatistics Unit, Forvie Site, Cambridge, UK, cDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge, UK, dThe Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital, Manchester, UK, eCystic Fibrosis Unit, Papworth Hospital, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  • D A Lomas aRespiratory Medicine Unit, Department of Medicine and Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK, bMRC Biostatistics Unit, Forvie Site, Cambridge, UK, cDepartment of Paediatrics, Addenbrooke's Hospital, Cambridge, UK, dThe Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital, Manchester, UK, eCystic Fibrosis Unit, Papworth Hospital, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  1. Dr R Mahadevarm232{at}cam.ac.uk
View Full Text

Citation

Mahadeva R, Sharples L, Ross-Russell RI, et al
Association of α1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis

Publication history

  • Received April 17, 2000
  • Revision requested June 16, 2000
  • Revised July 28, 2000
  • Accepted September 8, 2000
  • First published January 1, 2001.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.